Trial intelligence / Profile preview

Turmeric and Tulsi for Frailty in Elderly

NCT03365310Unknown

Sponsor
Composite Interceptive Med-Science Laboratories
Start
Jul 2018
Primary completion
Jul 2018
Countries
1
01

Overview

Randomised, open-label trial (2 arms), sponsored by Composite Interceptive Med-Science Laboratories. Primary endpoint: Frailty Score at 3 months. Status: unknown.

Beyond the preview

Go deeper on NCT03365310.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03365310.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call